Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The fate of 4-hydroxycarbazole metabolite: metabolism and carcinogenicity assessment of a β-adrenergic receptor modulator containing carbazole structure.

Autor: He, Minxia M., Ji, Tao, Barbuch, Robert J., Campanale, Kristina, Lantz, Ron, Hadden, Chad, Wilke, August

Publikováno v: Xenobiotica; Dec2011, Vol. 41 Issue 12, p1108-1121, 14p

Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study.

Autor: Guttman-Yassky, Emma, Silverberg, Jonathan I, Nemoto, Osamu, Forman, Seth B, Wilke, August, Prescilla, Randy, de la Peña, Amparo, Nunes, Fabio P, Janes, Jonathan, Gamalo, Margaret, Donley, David, Paik, Jim, DeLozier, Amy M, Nickoloff, Brian J, Simpson, Eric L

Publikováno v: Journal of the American Academy of Dermatology; Feb2018, Vol. 78 Issue 2, pN.PAG-N.PAG, 1p

Characterization of dark liver pigment observed in rats after subchronic dosing of the beta3-adrenergic receptor agonist LY368842.

Autor: He MM; Drug Disposition, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA. he_michelle_minxia@lilly.com, Barbuch RJ, Abraham TL, Lindsay TJ, Jackson DA, Ackermann BL, Wilke AV, Jensen CB

Publikováno v: Chemical research in toxicology [Chem Res Toxicol] 2003 Jul; Vol. 16 (7), pp. 912-9.